Bio Path | BPTH - Pre Tax Profit


Bio Path reported $-976K in Pre-Tax Profit for its fiscal quarter ending in September of 2025.





Pre Tax Profit Change Date
Alterity Therapeutics Limited AUD -4.74M 3.53M Dec/2024
Baxter International USD 121M 12M Sep/2025
Bio Path USD -976K 3.62M Sep/2025
Cipla INR 11.69B 6.85B Dec/2025
Clal Biotechnology ILS 86.82M 17.9M Dec/2022
Compugen USD 56.84M 63.78M Dec/2025
CSL USD 2.61B 1.21B Dec/2025
Grifols EUR 257.85M 190.87M Dec/2024
Karyopharm Therapeutics USD -39.9M 9.01M Dec/2025